|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss attributable to the common stockholders | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation expense | ||||
| Impairment of assets | ||||
| Amortization expense | ||||
| Warrants issued for services | ||||
| Stock based compensation - related parties | ||||
| Inventory | ||||
| Accounts receivable | ||||
| Other current assets | ||||
| Accounts payable and accrued expenses | ||||
| Short-term note payable | ||||
| Other current liabilities | ||||
| Net cash used in operating activities | ||||
| Cash flows from investing activities: | ||||
| Acquisition of intangible assets | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities: | ||||
| Advance from shareholder | ||||
| Issuance of common stock for cash | ||||
| Net cash provided by financing activities | ||||
| Net increase in cash | ||||
| Cash at beginning of year | ||||
| Cash at end of year | ||||
| Non-cash investing and financing activities: | ||||
| Common stock issued for conversion of short-term note payable and accrued interest | ||||
| Common stock issued in conjunction with share agreement | ||||
Loading...